Skip Navigation
Skip to contents

ACC : Acute and Critical Care

OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
7 "nasal cannula"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Original Articles
Pediatrics
High-flow nasal cannula for respiratory support in children with severe asthma attack: a systematic review and meta-analysis
Ghea Mangkuliguna, Muhammad Ifan Romli, Adrian Djatikusumo, Nicholas Adrianto
Acute Crit Care. 2026;41(1):148-159.   Published online October 24, 2025
DOI: https://doi.org/10.4266/acc.003744
  • 1,340 View
  • 91 Download
AbstractAbstract PDF
Background
Adjunctive therapies, including high-flow nasal cannula (HFNC) and bilevel positive airway pressure, have been explored to manage severe asthma attacks and avoid invasive ventilation. HFNC has gained interest as a potential alternative. This review evaluated and compared outcomes of HFNC with conventional oxygen therapy or other non-invasive ventilation (NIV) in severe asthma. Methods: A comprehensive search of PubMed/Medline, Scopus, Cochrane Library, and gray literature identified studies published between August 25, 2014, and August 25, 2024. A random-effects meta-analysis was performed, and results were presented in a forest plot. Study quality was assessed using the Cochrane Risk of Bias tool (ROB-2) and Newcastle-Ottawa Scale. The review followed Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guidelines and was registered in PROSPERO (CRD42024558656). Results: Nine studies with 14,606 subjects were included. HFNC showed a trend toward improved pulmonary scores, though not statistically significant (P>0.05). Pediatric intensive care unit (PICU) admission and need for escalation of support did not significantly differ from standard oxygen therapy or other NIV. HFNC was associated with a modest but significant increase in readmission (odds ratio, 3.14; 95% CI, 1.07–9.24; P=0.04). PICU length of stay was comparable across groups, and mortality among HFNC-treated patients remained <1%. Overall evidence quality was very low to low. Conclusions: HFNC did not demonstrate superior outcomes over conventional oxygen therapy and other NIV. Evidence remains limited and of low quality, highlighting the need for further high-quality studies.
Pulmonary
Comparison of preoxygenation with a high-flow nasal cannula and a simple face mask before intubation in Korean patients with head and neck cancer
Jun-Young Jo, Jungpil Yoon, Heeyoon Jang, Wook-Jong Kim, Seungwoo Ku, Seong-Soo Choi
Acute Crit Care. 2024;39(1):61-69.   Published online January 26, 2024
DOI: https://doi.org/10.4266/acc.2022.01543
  • 7,870 View
  • 275 Download
  • 5 Web of Science
  • 5 Crossref
AbstractAbstract PDFSupplementary Material
Background
Although preoxygenation is an essential procedure for safe endotracheal intubation, in some cases securing sufficient time for tracheal intubation may not be possible. Patients with head and neck cancer might have a difficult airway and need a longer time for endotracheal intubation. We hypothesized that the extended apneic period with preoxygenation via a high-flow nasal cannula (HFNC) is beneficial to patients who undergo head and neck surgery compared with preoxygenation with a simple mask.
Methods
The study was conducted as a single-center, single-blinded, prospective, randomized controlled trial. Patients were divided into groups based on one of the two preoxygenation methods: HFNC group or simple facemask (mask group). Preoxygenation was performed for 5 minutes with each method, and endotracheal intubation for all patients was performed using a video laryngoscope. Oxygen partial pressures of the arterial blood were compared at the predefined time points.
Results
For the primary outcome, the mean arterial oxygen partial pressure (PaO2 ) immediately after intubation was 454.2 mm Hg (95% confidence interval [CI], 416.9–491.5 mm Hg) in the HFNC group and 370.7 mm Hg (95% CI, 333.7–407.4 mm Hg) in the mask group (P=0.002). The peak PaO2 at 5 minutes after preoxygenation was not statistically different between the groups (P=0.355).
Conclusions
Preoxygenation with a HFNC extending to the apneic period before endotracheal intubation may be beneficial in patients with head and neck cancer.

Citations

Citations to this article as recorded by  
  • High-flow nasal oxygen versus face-mask ventilation for rapid sequence induction in non-elective surgical patients: a randomized controlled trial
    Nguyen Duc Lam, Le Dinh Thanh Son, Tran Minh Phat, Nguyen Dang Thu, Nguyen Thuy Nga, Vuong Trung Son, Bui Minh Hong
    BMC Anesthesiology.2026;[Epub]     CrossRef
  • High-Flow Nasal Cannula Oxygen Therapy in Perioperative Respiratory Care: Application and Prospects
    Jing Chen, Xinyue Hu, Dong Han, Yuwei Liu, Danqi Chen, Shuangyun Chen, Yuwei Chen, Jing Wu
    Journal of Multidisciplinary Healthcare.2026; Volume 19: 1.     CrossRef
  • Guidelines 2024: Emergency intubation of an adult outside the operating room and intensive care unit
    Thomas Clavier, Eric Cesareo, Denis Frasca, Frédéric Adnet, Marie-Pierre Bonnet, Nathalie Bruneau, Xavier Combes, Julie Contenti, Anne-Laure Feral-Pierssens, Michel Galinski, Jérémy Guenezan, Cédric Gil-Jardine, Alice Hutin, Samir Jaber, Déborah Jaeger, F
    Anaesthesia Critical Care & Pain Medicine.2026; 45(3): 101744.     CrossRef
  • Application Progress of Nasal High-Flow Oxygen Therapy in Clinical Anesthesia
    雨 张
    Advances in Clinical Medicine.2026; 16(04): 76.     CrossRef
  • Place de l’oxygénation haut débit dans la gestion des voies aériennes au bloc opératoire
    Antoine Duwat, Romain Deransy
    Anesthésie & Réanimation.2025; 11(5-6): 393.     CrossRef
Pulmonary
Combining reservoir mask oxygenation with high-flow nasal cannula in the treatment of hypoxemic respiratory failure among patients with COVID-19 pneumonia: a retrospective cohort study
Ivan Gur, Ronen Zalts, Yaniv Dotan, Khitam Hussain, Ami Neuberger, Eyal Fuchs
Acute Crit Care. 2023;38(4):435-441.   Published online November 23, 2023
DOI: https://doi.org/10.4266/acc.2023.00451
  • 9,431 View
  • 136 Download
  • 1 Web of Science
AbstractAbstract PDFSupplementary Material
Background
Concerns regarding positive-pressure-ventilation for the treatment of coronavirus disease 2019 (COVID-19) hypoxemia led the search for alternative oxygenation techniques. This study aimed to assess one such method, dual oxygenation, i.e., the addition of a reservoir mask (RM) on top of a high-flow nasal cannula (HFNC).
Methods
In this retrospective cohort study, the records of all patients hospitalized with COVID-19 during 2020–2022 were reviewed. Patients over the age of 18 years with hypoxemia necessitating HFNC were included. Exclusion criteria were positive-pressure-ventilation for any indication other than hypoxemic respiratory failure, transfer to another facility while still on HFNC and “do-not-intubate/resuscitate” orders. The primary outcome was mortality within 30 days from the first application of HFNC. Secondary outcomes were intubation and admission to the intensive care unit.
Results
Of 659 patients included in the final analysis, 316 were treated with dual oxygenation and 343 with HFNC alone. Propensity for treatment was estimated based on background diagnoses, laboratories and vital signs upon admission, gender and glucocorticoid dose. Inverse probability of treatment weighted regression including age, body mass index, Sequential Organ Failure Assessment (SOFA) score and respiratory rate oxygenation index showed treatment with dual oxygenation to be associated with lower 30-day mortality (adjusted hazard ratio, 0.615; 95% confidence interval, 0.469–0.809). Differences in the secondary outcomes did not reach statistical significance.
Conclusions
Our study suggests that the addition of RM on top of HFNC may be associated with decreased mortality in patients with severe COVID-19 hypoxemia.
Pulmonary
Comparison of high-flow nasal oxygen therapy and noninvasive ventilation in COVID-19 patients: a systematic review and meta-analysis
Glenardi Glenardi, Febie Chriestya, Bambang J Oetoro, Ghea Mangkuliguna, Natalia Natalia
Acute Crit Care. 2022;37(1):71-83.   Published online February 22, 2022
DOI: https://doi.org/10.4266/acc.2021.01326
  • 18,116 View
  • 559 Download
  • 11 Web of Science
  • 10 Crossref
AbstractAbstract PDFSupplementary Material
Background
Acute respiratory failure (ARF) is a major adverse event commonly encountered in severe coronavirus disease 2019 (COVID-19). Although noninvasive mechanical ventilation (NIV) has long been used in the management of ARF, it has several adverse events which may cause patient discomfort and lead to treatment complication. Recently, high-flow nasal cannula (HFNC) has the potential to be an alternative for NIV in adults with ARF, including COVID-19 patients. The objective was to investigate the efficacy of HFNC compared to NIV in COVID-19 patients.
Methods
This meta-analysis was reported following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) criteria. Literature search was carried out in electronic databases for relevant articles published prior to June 2021. The protocol used in this study has been registered in International Prospective Register of Systematic Reviews (CRD42020225186).
Results
Although the success rate of NIV is higher compared to HFNC (odds ratio [OR], 0.39; 95% confidence interval [CI], 0.16–0.97; P=0.04), this study showed that the mortality in the NIV group is also significantly higher compared to HFNC group (OR, 0.49; 95% CI, 0.39–0.63; P<0.001). Moreover, this study also demonstrated that there was no significant difference in intubation rates between the two groups (OR, 1.35; 95% CI, 0.86–2.11; P=0.19).
Conclusions
Patients treated with HFNC showed better outcomes compared to NIV for ARF due to COVID-19. Therefore, HFNC should be considered prior to NIV in COVID-19–associated ARF. However, further studies with larger sample sizes are still needed to better elucidate the benefit of HFNC in COVID-19 patients.

Citations

Citations to this article as recorded by  
  • Trends and management of acute respiratory failure in hospitalized patients: a multicenter retrospective study in South Korea
    Won Jin Yang, Yong Jun Choi, Kyung Soo Chung, Ji Soo Choi, Bo Mi Jung, Jae Hwa Cho
    Acute and Critical Care.2025; 40(2): 171.     CrossRef
  • 2023 Year in Review: High-Flow Nasal Cannula for COVID-19
    Michael D Davis
    Respiratory Care.2024; 69(12): 1587.     CrossRef
  • High-flow nasal cannula therapy in patients with COVID-19 in intensive care units in a country with limited resources: a single-center experience
    Anh-Minh Vu Phan, Hai-Yen Thi Hoang, Thanh-Son Truong Do, Trung Quoc Hoang, Thuan Van Phan, Nguyet-Anh Phuong Huynh, Khoi Minh Le
    Journal of International Medical Research.2023;[Epub]     CrossRef
  • Evaluating the use of the respiratory-rate oxygenation index as a predictor of high-flow nasal cannula oxygen failure in COVID-19
    Scott Weerasuriya, Savvas Vlachos, Ahmed Bobo, Namitha Birur Jayaprabhu, Lauren Matthews, Adam R Blackstock, Victoria Metaxa
    Acute and Critical Care.2023; 38(1): 31.     CrossRef
  • Does the variant positivity and negativity affect the clinical course in COVID-19?: A cohort study
    Erkan Yildirim, Levent Kilickan, Suleyman Hilmi Aksoy, Ramazan Gozukucuk, Hasan Huseyin Kilic, Yakup Tomak, Orhan Dalkilic, Ibrahim Halil Tanboga, Fevzi Duhan Berkan Kilickan
    Medicine.2023; 102(9): e33132.     CrossRef
  • The COVID-19 Driving Force: How It Shaped the Evidence of Non-Invasive Respiratory Support
    Yorschua Jalil, Martina Ferioli, Martin Dres
    Journal of Clinical Medicine.2023; 12(10): 3486.     CrossRef
  • Descriptive account of the first use of the LeVe CPAP System, a new frugal CPAP System, in adult patients with COVID-19 Pneumonitis in Uganda
    Anna Littlejohns, Helen Please, Racheal Musasizi, Stuart Murdoch, Gorret Nampiina, Ian Waters, William Davis Birch, Gregory de Boer, Nikil Kapur, Tumwesigye Ambrozi, Ninsiima Carol, Nakigudde Noel, Jiten Parmar, Peter Culmer, Tom Lawton, Edith Namulema
    Tropical Medicine and Health.2023;[Epub]     CrossRef
  • Mechanical ventilation and outcomes in COVID-19 patients admitted to intensive care unit in a low-resources setting: A retrospective study
    Sarakawabalo Assenouwe, Tabana Essohanam Mouzou, Ernest Ahounou, Lidaw Déassoua Bawe, Awèréou Kotosso, Koffi Atsu Aziagbe, Eyram Makafui Yoan Amekoudi, Mamoudou Omourou, Chimene Etonga Anoudem, Komi Séraphin Adjoh
    Journal of Acute Disease.2023; 12(5): 186.     CrossRef
  • Comparison between high-flow nasal cannula and noninvasive ventilation in COVID-19 patients: a systematic review and meta-analysis
    Yun Peng, Bing Dai, Hong-wen Zhao, Wei Wang, Jian Kang, Hai-jia Hou, Wei Tan
    Therapeutic Advances in Respiratory Disease.2022;[Epub]     CrossRef
  • Does High Flow Nasal Cannula avoid intubation and improve the mortality of adult patients in acute respiratory failure in the intensive care setting, when compared to others methods as Conventional Oxygen Therapy or Non-Invasive Ventilation? A narrative r
    P Fosseur, A Renard, P Mateu, J Rosman
    Acta Anaesthesiologica Belgica.2022; 73(Supplement): 97.     CrossRef
Review Article
Pulmonary
High-flow nasal cannula for respiratory failure in adult patients
SeungYong Park
Acute Crit Care. 2021;36(4):275-285.   Published online November 30, 2021
DOI: https://doi.org/10.4266/acc.2021.01571
  • 65,535 View
  • 1,887 Download
  • 34 Web of Science
  • 37 Crossref
AbstractAbstract PDF
The high-flow nasal cannula (HFNC) has been recently used in several clinical settings for oxygenation in adults. In particular, the advantages of HFNC compared with low-flow oxygen systems or non-invasive ventilation include enhanced comfort, increased humidification of secretions to facilitate expectoration, washout of nasopharyngeal dead space to improve the efficiency of ventilation, provision of a small positive end-inspiratory pressure effect, and fixed and rapid delivery of an accurate fraction of inspired oxygen (FiO2) by minimizing the entrainment of room air. HFNC has been successfully used in critically ill patients with several conditions, such as hypoxemic respiratory failure, hypercapneic respiratory failure (exacerbation of chronic obstructive lung disease), post-extubation respiratory failure, pre-intubation oxygenation, and others. However, the indications are not absolute, and much of the proven benefit remains subjective and physiologic. This review discusses the practical application and clinical uses of HFNC in adults, including its unique respiratory physiologic effects, device settings, and clinical indications.

Citations

Citations to this article as recorded by  
  • Prediction of high-flow nasal cannula failure in critically ill patients: a narrative review
    Yaxiaerjiang Muhetaer, Shi-min Zhang, Amanguli Moming, Kai Liu, Ming Zhong
    Journal of Intensive Care.2026;[Epub]     CrossRef
  • Heated and Humidified Oxygen in Critical Care Transport: Evaluating the Use of Aerogen Pro-X Nebulizer as an Alternative to Traditional High-Flow Humidifiers
    Maria Karas, Trace Choulat, Jamie Persten, Conner Rucks, Ravi Panchigar, Emma Beqaj, Emily Puckett, Andrew Joseph, Derek Hunt
    Air Medical Journal.2026;[Epub]     CrossRef
  • The effect of high-flow nasal cannula oxygen therapy on preventing hypoxemia during deep sedation extubation after laparoscopic surgery: a prospective randomized controlled trial
    Yi-Kai Wang, Xiang Li, Shi-You Wei, Hui Yang, Zhou-Peng Tan, Sheng-Ming Yan, Wei Liu, Xin Lv
    BMC Anesthesiology.2026;[Epub]     CrossRef
  • Adherence and influencing factors of high-flow nasal cannula humidified oxygen therapy in elderly patients with stable chronic obstructive pulmonary disease: A meta-analysis
    Yang Yang, Ting-Ting Liu, Dong-Mei Li, Xue-Ling Ren, Zheng Luo, Xue-Li Chen, Ying-Zhen Du, Yan-Shuang Cheng
    Annals of Thoracic Medicine.2025; 20(1): 49.     CrossRef
  • Comparison of high flow nasal cannula and conventional oxygen therapy post-extubation in intensive care unit: A prospective crossover observational study
    Govindraj M Bhat, Anil R Shetty, Gouri Pratyusha Kintamani
    Indian Journal of Clinical Anaesthesia.2025; 12(1): 125.     CrossRef
  • Impact of the Early Use of High-flow Nasal Cannula in Patients with Post-traumatic Lung Contusion: A Randomized Clinical Trial
    Rania G Elsayed, Amr F Hafez, Mohammed M Maarouf, Farouk KE AbdElAziz
    Indian Journal of Critical Care Medicine.2025; 29(2): 117.     CrossRef
  • Comparison of high-flow nasal oxygen therapy and noninvasive ventilation in suspected sepsis patients with acute respiratory distress in the emergency department: a retrospective cohort study
    Chuenruthai Angkoontassaneeyarat, Prapimporn Charoenphon, Pitsucha Sanguanwit, Chaiyaporn Yuksen, Suteenun Seesuklom
    International Journal of Emergency Medicine.2025;[Epub]     CrossRef
  • Comparison of Procedural Oxygen Mask and Nasal Cannula in Endoscopic Procedures: A Prospective Observational Study
    Aydogan Celik, Mehmet Yilmaz, Ahmet Yuksek, Sema Candan, Ayse Zeynep Turan Civraz, Merve Yazici Kara, Bedirhan Gunel
    Bratislava Medical Journal.2025; 126(6): 1085.     CrossRef
  • A comparison of conventional high-flow nasal cannula vs the duet high-flow nasal cannula in extubated patients: a randomized crossover trial
    Ravindranath Tiruvoipati, Mallikarjuna Ponnapa Reddy, Eldho Paul, Sachin Gupta, Ashwin Subramaniam, David Zhang, Kavi Haji
    European Journal of Medical Research.2025;[Epub]     CrossRef
  • Home High-Flow Nasal Cannula in Patients with Chronic Respiratory Failure: A Literature Review and Suggestions for Clinical Practice
    Youjin Chang, Moon Seong Baek, Sei Won Kim, Su Hwan Lee, Jung Soo Kim, So Young Park, Jin Woo Kim, Jae Hwa Cho, Sunghoon Park
    Tuberculosis and Respiratory Diseases.2025; 88(2): 264.     CrossRef
  • Unraveling relevant cross-waves pattern drifts in patient-hospital risk factors among hospitalized COVID-19 patients using explainable machine learning methods
    Fernanda Cristina Barbosa Lana, Carolina Coimbra Marinho, Bruno Barbosa Miranda de Paiva, Lucas Rocha Valle, Guilherme Fonseca do Nascimento, Leonardo Chaves Dutra da Rocha, Marcelo Carneiro, Joanna d‘Arc Lyra Batista, Fernando Anschau, Pedro Gibson Parai
    BMC Infectious Diseases.2025;[Epub]     CrossRef
  • THRIVE Prevent Postoperative Hypoxemia in Elderly Patients Undergoing Laparoscopic Surgery in PACU: A Randomized Controlled Clinical Trial
    Xingxing Chen, Kang Gu, Yunqing Yang, Bingbing Zhou, Yunchang Mo, Yingying Tu
    Journal of Multidisciplinary Healthcare.2025; Volume 18: 2651.     CrossRef
  • Implementation of High-Flow Oxygen Therapy in a Surgical High-Dependency Unit: A Cohort Study
    Joanne Chong Hui Ling , Bridget Ng Si Min, Shi Min Tan, Wei Qin Teo, Irene Too Ai Ling, Jolin Wong, Vui K Ho, Shin Yi Ng, Aarthi Suhitharan, Suhitharan Thangavelautham
    Cureus.2025;[Epub]     CrossRef
  • Trends and management of acute respiratory failure in hospitalized patients: a multicenter retrospective study in South Korea
    Won Jin Yang, Yong Jun Choi, Kyung Soo Chung, Ji Soo Choi, Bo Mi Jung, Jae Hwa Cho
    Acute and Critical Care.2025; 40(2): 171.     CrossRef
  • Breathing Easy
    Stephanie Gregory, Sandra Waugaman, Sarah Zeller
    Critical Care Nursing Clinics of North America.2025; 37(3): 461.     CrossRef
  • Factors affecting critical care outcomes in the emergency department
    Taylor M. Fontenot, Ioana Antonescu, Heatherlee Bailey
    Current Opinion in Critical Care.2025; 31(5): 566.     CrossRef
  • Comparison of three different flow rates of oxygen with high-flow nasal cannula versus conventional nasal oxygen therapy in adult patients undergoing endoscopic retrograde cholangiopancreatography
    Arundhati Chadha, Anil Yogendra Yadav, Udit Dhingra, Gaurav Sindwani, Vinod Arora, Deepak K. Tempe
    Trends in Anaesthesia and Critical Care.2025; 65: 101600.     CrossRef
  • Practice of High-Flow Nasal Cannula in Patients with Mild to Moderate COPD Among Healthcare Providers in Saudi Arabia: A Cross-Sectional Study
    Abdulelah Aldhahir, Mohammed Alyami, Osama Alanazi, Ahmed Alasimi, Abdullah Alqarni, Jaber Alqahtani, Abdallah Naser, Hassan Alwafi, Mohammad Dairi, Saeed Alghamdi, Rayan Siraj, Nowaf Alobaidi, Mohammed Almeshari, Abdulrhman Alghamdi
    Journal of Multidisciplinary Healthcare.2025; Volume 18: 7567.     CrossRef
  • Continuous non-invasive measurement of tidal volume and minute ventilation using a smart nasal cannula
    Alan B. Dogan, Neel Patel, Carter Gottschalk, Rae L. Blankenship, Valerie K. Young, Alfred Wicks, Umar F. Sofi
    Critical Care.2025;[Epub]     CrossRef
  • Effect of high-flow nasal cannula therapy on adults with obstructive sleep apnea: A meta-analysis
    Shuang Bian, Jiaqi Di, Kai Shi, Dongwei Yu, Yuejuan Feng
    Medicine.2025; 104(48): e45782.     CrossRef
  • Physical and Physiological Mechanisms of Emergent Hydrodynamic Pressure in High-Flow Nasal Cannula Therapy
    Jose Luis Estela-Zape
    Advances in Respiratory Medicine.2025; 94(1): 1.     CrossRef
  • Asymmetrical high-flow nasal cannula performs similarly to standard interface in patients with acute hypoxemic post-extubation respiratory failure: a pilot study
    Annalisa Boscolo, Tommaso Pettenuzzo, Francesco Zarantonello, Nicolò Sella, Elisa Pistollato, Alessandro De Cassai, Sabrina Congedi, Irene Paiusco, Giacomo Bertoldo, Silvia Crociani, Francesca Toma, Giulia Mormando, Giulia Lorenzoni, Dario Gregori, Paolo
    BMC Pulmonary Medicine.2024;[Epub]     CrossRef
  • Recommendations from The Medical Education Editor
    Mark Lavercombe
    Respirology.2024; 29(4): 266.     CrossRef
  • Liberation from mechanical ventilation in critically ill patients: Korean Society of Critical Care Medicine Clinical Practice Guidelines
    Tae Sun Ha, Dong Kyu Oh, Hak-Jae Lee, Youjin Chang, In Seok Jeong, Yun Su Sim, Suk-Kyung Hong, Sunghoon Park, Gee Young Suh, So Young Park
    Acute and Critical Care.2024; 39(1): 1.     CrossRef
  • Clinical Practice of High-Flow Nasal Cannula Therapy in ARDS Patients: A Cross-Sectional Survey of Respiratory Therapists
    Mohammed Alyami, Abdulelah Aldhahir, Abdullah Alqarni, Khalid Salwi, Abdullah Sarhan, Mohammed Almeshari, Nowaf Alobaidi, Jaber Alqahtani, Rayan Siraj, Abdullah Alsulayyim, Saeed Alghamdi, Ahmed Alasimi, Omar Alqarni, Mansour Majrshi, Hassan Alwafi
    Journal of Multidisciplinary Healthcare.2024; Volume 17: 1401.     CrossRef
  • Evaluating high-flow oxygen therapy after mechanical thrombectomy under general anesthesia in acute ischemic stroke: A retrospective single-center study
    Pingyou He, Xiang Bao, FengFeng Jiang, Xiaobo Liu, Wei Xu, Danfeng Yu, Lin Chen, Feng Chen
    Clinical Neurology and Neurosurgery.2024; 243: 108359.     CrossRef
  • A Comprehensive Review on High-Flow Nasal Cannula Oxygen Therapy in Critical Care: Evidence-Based Insights and Future Directions
    Shubham Petkar, Dnyanshree Wanjari, Vishnu Priya
    Cureus.2024;[Epub]     CrossRef
  • Does apneic oxygenation with nasopharyngeal cannula during intubation improve the oxygenation in patients with acute hypoxemic respiratory failure compared to the standard bag valve mask preoxygenation? An open-labeled randomized control trial
    Irfan Zubair Shahul Hameed, Darpanarayan Hazra, Priya Ganesan, Abhilash Kundavaram Paul Prabhakar
    Turkish Journal of Emergency Medicine.2024; 24(1): 33.     CrossRef
  • Liberation from Mechanical Ventilation in Critically Ill Patients: Korean Society of Critical Care Medicine Clinical Practice Guidelines
    Tae Sun Ha, Dong Kyu Oh, Hak-Jae Lee, Youjin Chang, In Seok Jeong, Yun Su Sim, Suk-Kyung Hong, Sunghoon Park, Gee Young Suh, So Young Park
    Tuberculosis and Respiratory Diseases.2024; 87(4): 415.     CrossRef
  • High-Flow and Low-Flow Oxygen Delivery by Nasal Cannula Evaluated in Infant and Adult Airway Replicas
    Mozhgan Sabz, Michelle L Noga, Warren H Finlay, Hossein Rouhani, Andrew R Martin
    Respiratory Care.2024; 69(4): 438.     CrossRef
  • Recomendaciones de terapia de alto flujo nasal en el servicio de Urgencias PARTE 1
    Saúl Trejo-Rosas, Ignacio Alberto Mendez-Jesus, Elizabeth Mendoza-Portillo, David Sanabría-Cordero, Miguel Russi-Hernández
    Archivos de Medicina de Urgencia de México.2024; 16(3): 210.     CrossRef
  • The Impact of High-Flow Nasal Cannula Therapy on Acute Respiratory Distress Syndrome Patients: A Systematic Review
    Ahmed M Abdelbaky, Wael G Elmasry , Ahmed H. Awad, Sarrosh Khan, Maryam Jarrahi
    Cureus.2023;[Epub]     CrossRef
  • High-Flow Oxygen Therapy in the Perioperative Setting and Procedural Sedation: A Review of Current Evidence
    Lou’i Al-Husinat, Basil Jouryyeh, Ahlam Rawashdeh, Abdelrahman Alenaizat, Mohammad Abushehab, Mohammad Wasfi Amir, Zaid Al Modanat, Denise Battaglini, Gilda Cinnella
    Journal of Clinical Medicine.2023; 12(20): 6685.     CrossRef
  • Current status of treatment of acute respiratory failure in Korea
    Yong Jun Choi, Jae Hwa Cho
    Journal of the Korean Medical Association.2022; 65(3): 124.     CrossRef
  • Transnasal High-Flow Oxygen Therapy versus Noninvasive Positive Pressure Ventilation in the Treatment of COPD with Type II Respiratory Failure: A Meta-Analysis
    Wei Liu, Mingli Zhu, Liuqin Xia, Xiangying Yang, Pei Huang, Yanming Sun, Ye Shen, Jianping Ma, Gang Chen
    Computational and Mathematical Methods in Medicine.2022; 2022: 1.     CrossRef
  • Association between timing of intubation and mortality in patients with idiopathic pulmonary fibrosis
    Eunhye Bae, Jimyung Park, Sun Mi Choi, Jinwoo Lee, Sang-Min Lee, Hong Yeul Lee
    Acute and Critical Care.2022; 37(4): 561.     CrossRef
  • Effect of high-flow oxygen versus T-piece ventilation strategies during spontaneous breathing trials on weaning failure among patients receiving mechanical ventilation: a randomized controlled trial
    Hong Yeul Lee, Jinwoo Lee, Sang-Min Lee
    Critical Care.2022;[Epub]     CrossRef
Original Articles
Pulmonary
Effects of high-flow nasal cannula in patients with mild to moderate hypercapnia: a prospective observational study
Kyung Hun Nam, Hyung Koo Kang, Sung-Soon Lee, So-Hee Park, Sung Wook Kang, Jea Jun Hwang, So Young Park, Won Young Kim, Hee Jung Suh, Eun Young Kim, Ga Jin Seo, Younsuck Koh, Sang-Bum Hong, Jin Won Huh, Chae-Man Lim
Acute Crit Care. 2021;36(3):249-255.   Published online July 26, 2021
DOI: https://doi.org/10.4266/acc.2020.01102
  • 12,555 View
  • 316 Download
  • 7 Web of Science
  • 9 Crossref
AbstractAbstract PDF
Background
Evidence for using high-flow nasal cannula (HFNC) in hypercapnia is still limited. Most of the clinical studies had been conducted retrospectively, and there had been conflicting reports for the effects of HFNC on hypercapnia correction in prospective studies. Therefore, more evidence is needed to understand the effect of the HFNC in hypercapnia.
Methods
We conducted a multicenter prospective observational study after applying HFNC to 45 hospitalized subjects who had moderate hypercapnia (arterial partial pressure of carbon dioxide [PaCO2], 43–70 mm Hg) without severe respiratory acidosis (pH <7.30). The primary outcome was a change in PaCO2 level in the first 24 hours of HFNC use. The secondary outcomes were changes in other parameters of arterial blood gas analysis, changes in respiration rates, and clinical outcomes.
Results
There was a significant decrease in PaCO2 in the first hour of HFNC application (-3.80 mm Hg; 95% confidence interval, -6.35 to -1.24; P<0.001). Reduction of PaCO2 was more prominent in subjects who did not have underlying obstructive lung disease. There was a correction in pH, but no significant changes in respiratory rate, bicarbonate, and arterial partial pressure of oxygen/fraction of inspired oxygen ratio. Mechanical ventilation was not required for 93.3% (42/45) of our study population.
Conclusions
We suggest that HFNC could be a safe alternative for oxygen delivery in hypercapnia patients who do not need immediate mechanical ventilation. With HFNC oxygenation, correction of hypercapnia could be expected, especially in patients who do not have obstructive lung diseases.

Citations

Citations to this article as recorded by  
  • Management of hypercapnic acute respiratory failure with high-flow nasal cannula therapy: A narrative review
    Christophe Girault, Elise Artaud-Macari, Pierre-Louis Declercq, Jean-Pierre Frat, Jean-Damien Ricard, Arnaud W. Thille, Gaëtan Béduneau
    Annals of Intensive Care.2026; 16: 100053.     CrossRef
  • A high-flow nasal cannula versus noninvasive ventilation in acute exacerbations of chronic obstructive pulmonary disease
    Oguzhan Haciosman, Huseyin Ergenc, Adem Az, Yunus Dogan, Ozgur Sogut
    The American Journal of Emergency Medicine.2025; 87: 38.     CrossRef
  • Successful Asymmetric Nasal High-Flow Therapy in CO₂ Narcosis Triggered by Pneumonia in an Elderly Patient: A Case Report
    Keita Takahashi, Shigeto Ishikawa, Akari Kusaka, Hiroyuki Takeuchi, Tomohiko Akahoshi
    Cureus.2025;[Epub]     CrossRef
  • Gas composition and pressure in the hypopharynx during high-flow oxygen therapy through a nasal cannula in healthy volunteers with different breathing patterns
    Andrey I. Yaroshetskiy, Anna P. Krasnoshchekova, Fedor D. Tkachenko, Alina V. Rubashchenko, Daniil D. Zubarev, Vasiliy D. Konanykhin, Maxim I. Savelenok, Maxim M. Nosenko, Zamira M. Merzhoeva, Sergey N. Avdeev
    BMC Anesthesiology.2025;[Epub]     CrossRef
  • Oxygénothérapie nasale à haut débit et insuffisance respiratoire aiguë hypercapnique
    C. Girault, E. Artaud-Macari, G. Jolly, D. Carpentier, A. Cuvelier, G. Béduneau
    Revue des Maladies Respiratoires.2024; 41(7): 498.     CrossRef
  • Safety and efficacy of high flow nasal canula in patients with mild hypercapnia
    Mohammed A. Ibrahim, Magdy Emara, Mohammed Shehta
    The Egyptian Journal of Bronchology.2023;[Epub]     CrossRef
  • Current status of treatment of acute respiratory failure in Korea
    Yong Jun Choi, Jae Hwa Cho
    Journal of the Korean Medical Association.2022; 65(3): 124.     CrossRef
  • High-flow nasal cannula: Evaluation of the perceptions of various performance aspects among Chinese clinical staff and establishment of a multidimensional clinical evaluation system
    Ruoxuan Wen, Xingshuo Hu, Tengchen Wei, Kaifei Wang, Zhimei Duan, Zhanqi Zhao, Lixin Xie, Fei Xie
    Frontiers in Medicine.2022;[Epub]     CrossRef
  • The Application Progress of HFNC in Respiratory Diseases
    迪 吴
    Advances in Clinical Medicine.2022; 12(11): 10617.     CrossRef
Pulmonary
Protecting Postextubation Respiratory Failure and Reintubation by High-Flow Nasal Cannula Compared to Low-Flow Oxygen System: Single Center Retrospective Study and Literature Review
Minhyeok Lee, Ji Hye Kim, In Beom Jeong, Ji Woong Son, Moon Jun Na, Sun Jung Kwon
Acute Crit Care. 2019;34(1):60-70.   Published online February 28, 2019
DOI: https://doi.org/10.4266/acc.2018.00311
  • 11,832 View
  • 230 Download
  • 6 Web of Science
  • 5 Crossref
AbstractAbstract PDFSupplementary Material
Background
Use of a high-flow nasal cannula (HFNC) reduced postextubation respiratory failure (PERF) and reintubation rate compared to use of a low-flow oxygen system (LFOS) in low-risk patients. However, no obvious conclusion was reached for high-risk patients. Here, we sought to present the current status of HFNC use as adjunctive oxygen therapy in a clinical setting and to elucidate the nature of the protective effect following extubation.
Methods
The medical records of 855 patients who were admitted to the intensive care unit of single university hospital during a period of 5.5 years were analyzed retrospectively, with only 118 patients ultimately included in the present research. The baseline characteristics of these patients and the occurrence of PERF and reintubation along with physiologic changes were analyzed.
Results
Eighty-four patients underwent HFNC, and the remaining 34 patients underwent conventional LFOS after extubation. Physicians preferred HFNC to LFOS in the face of highrisk features including old age, neurologic disease, moderate to severe chronic obstructive pulmonary disease, a long duration of mechanical ventilation, low baseline arterial partial pressure of oxygen to fraction of inspired oxygen ratio, and a high baseline alveolar–arterial oxygen difference. The reintubation rate at 72 hours after extubation was not different (9.5% vs. 8.8%; P=1.000). Hypoxic respiratory failure was slightly higher in the nonreintubation group than in the reintubation group (31.9% vs. 6.7%; P=0.058). Regarding physiologic effects, heart rate was only stabilized after 24 hours of extubation in the HFNC group.
Conclusions
No difference was found in the occurrence of PERF and reintubation between both groups. It is worth noting that similar PERF and reintubation ratios were shown in the HFNC group in those with certain exacerbating risk factors versus not. Caution is needed regarding delayed reintubation in the HFNC group.

Citations

Citations to this article as recorded by  
  • High-flow nasal therapy vs conventional oxygen therapy in mild COVID-19 hypoxaemia: a Bayesian reanalysis of the COVID-HIGH Trial
    Claudia Crimi, Salvatore Sardo, Alberto Noto, Fabiana Madotto, Mariachiara Ippolito, Santi Nolasco, Raffaele Campisi, Giuseppe Fiorentino, Ioannis Pantazopoulos, Athanasios Chalkias, Alessio Mattei, Raffaele Scala, Enrico Clini, Begum Ergan, Manel Lujan,
    Journal of Anesthesia, Analgesia and Critical Care.2026;[Epub]     CrossRef
  • Comparison of ROX index with modified indices incorporating heart rate, flow rate, and PaO2/FiO2 ratio for early prediction of outcomes among patients initiated on post-extubation high-flow nasal cannula therapy
    Smitesh Gutta, Wei Jun Dan Ong, Shanaz Matthew Sajeed, Belinda Zer Hui Chern, Monika Gulati Kansal, Faheem Ahmed Khan, Amit Kansal
    European Journal of Medical Research.2025;[Epub]     CrossRef
  • High-flow nasal oxygen therapy compared with conventional oxygen therapy in hospitalised patients with respiratory illness: a systematic review and meta-analysis
    Daniel Seow, Yet H Khor, Su-Wei Khung, David M Smallwood, Yvonne Ng, Amy Pascoe, Natasha Smallwood
    BMJ Open Respiratory Research.2024; 11(1): e002342.     CrossRef
  • Predictors and outcomes of high-flow nasal cannula failure following extubation: A multicentre observational study
    Amit Kansal, Shekhar Dhanvijay, Andrew Li, Jason Phua, Matthew Edward Cove, Wei Jun Dan Ong, Ser Hon Puah, Vicky Ng, Qiao Li Tan, Julipie Sumampong Manalansan, Michael Sharey Nocon Zamora, Michael Camba Vidanes, Juliet Tolentino Sahagun, Juvel Taculod, Ad
    Annals of the Academy of Medicine, Singapore.2021; 50(6): 467.     CrossRef
  • Flow Field Analysis of Adult High‐Flow Nasal Cannula Oxygen Therapy
    Jingen Xia, Jiaqi Chang, Jixiang Liang, Yixuan Wang, Na Wang, Bo Xiao
    Complexity.2021;[Epub]     CrossRef

ACC : Acute and Critical Care
TOP